EHA 2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
EHA 2024
Jun 29, 2024, 16:57 |
Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 26, 2024, 15:03 |
Blog
Summary of the top myeloma research presented at ASCO and EHA 2024 - IMF
International Myeloma Foundation shared a post on X: . "Join International Myeloma Foundation (IMF) virtually…
Jun 19, 2024, 14:18 |
Societies
Elena Torre: EHA 2024 concluded with an outstanding presentation by Claire Harrison
Elena Torre, Honorary Clinical Fellow at Guy’s and St Thomas’ NHS Foundation Trust, shared a post on…
May 25, 2024, 07:45 |
Blog
Join us for our Post-ASCO and EHA 2024 Highlights - Video Journal of Hematology and Hematological Oncology
Video Journal of Hematology and Hematological Oncology shared on X: "Join us for our Post-ASCO…
May 22, 2024, 01:53 |
Insight
Nitin Jain: Looking forward to presenting phase 2 trial of frontline treatment for patients with CLL at EHA 2024
Nitin Jain, Professor of the Department of Leukemia at MD Anderson Cancer Center, shared on…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube